We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
--
Could have been worse, could have been another collaboration agreement.
--------------------------------------
So, we have yet another health claim.
Can we hope for commercial success for such a health benefitting discovery?
Never mind that, here's another health benefit.
Yes, but, will it be a product which sees wide spread public awareness and market demand?
It's a very important health benefit.
Yes it is, so shall we wait and see then?
Yes.
Sigh, OK then.
What a load of rubbish.
The game here is all about China and China is having a crisis , they will start a war to distract from it by the looks of it. So not looking good for PXS.
So, we have yet another health claim.
Can we hope for commercial success for such a health benefitting discovery?
Never mind that, here's another health benefit.
Yes, but, will it be a product which sees wide spread public awareness and market demand?
It's a very important health benefit.
Yes it is, so shall we wait and see then?
Yes.
Sigh, OK then.
The Cykotine Storm one is based on Duttaroy's study
https://pubmed.ncbi.nlm.nih.gov/33421690/
If I sold my holding you would all be rich :)
lol Dr
so if you sell some the price should go up ?
W$
Cytokine inflammatory storm ?? Cytokine release syndrome, is a type of immune system inflammatory response syndrome that can occur due to illnesses like Covid. The very severe cases of this condition, called cytokine hurricanes. In simpler words, cytokine hurricane syndrome is a group of related diseases during which the immune system produces many inflammatory signals, sometimes even leading to failure and death. Cytokine hurricane Ken is due to field problems And different diseases happen. For example, in patients with severe coronavirus, cytokine storm syndrome occurs due to inflammation of the internal organs and the immune system response of the body. Most people with Corona do not experience Cytokine storm and only in very severe cases they suffer such an attack. When a person has a genetic history of specific disease or background infections, a virus, like Covid, is more likely to develop cytokine. Cytokine storms are a defective cycle that creates a dangerous condition in the immune system that causes inflammation, organ damage and death. Studies have shown that using Fruit Flu (the effective substance Vestolux) in the early stages of Covid, i.e. before Cytokine storms, can reduce the risk of inflammation, clots and cardiovascular diseases that cause Covid ?? ??
https://www.instagram.com/p/Cgq7g73lPLe/
Vestolux on Instagram letting the cat out of the bag wrt the upcoming patent perhaps??????
Microorganisms ? Our digestive system normally has microorganisms that help maintain the body’s health, boost the immune system and regulate metabolism as well as better absorption and digestion of nutrients from the gut. Microflour is made up of bacteria, fungi, and fermentation, all of which are present in our digestive system. Recent studies have shown that there is an inverse link between digestive microflora diversity and vascular system health. If microflora balance is disrupted or depopulated, it affects the vascular wall and makes the person vulnerable to cardiovascular disease, including sclerosis. One of the effects of Fruit Flow is regulating the population of microbiome of the digestive system, which can prevent the hardness of the vessel wall. ???? Check out our new website
https://www.instagram.com/reel/ChCMrwMFtGW/?igshid=MDJmNzVkMjY%3D
Another tick in the box :)
If anyone is curious why the price dropped in recent days, it is because I bought a few more shares. It happens every time I buy shares. Sorry to drag you down with me.
Everybody join me and buy some more shares :)
Proved my point small trades ,but the price went down
Me too. I'm now thinking we should be in a much better place in 3 to 4 years time. If i've kicked the bucket by then, it's the only time I'll be a good investor.
Hi Dr horrible ,Thank you for the adive ,i ve already have been invested here 12 years ,tou don't know how long will you live
Naz,
1p gives the company a market cap of about £22m. We are expecting that the company, in the short to medium term, will be making £5m to £10m, likely giving a market cap of £100m to £200m. If BH really do have a large number of multi-national companies ready to commercialise FF, it could be much.. much more. Then we have the hanging fruit that is that FF could become the recommended product for primary prevention of cardiovascular disease. It is what all the studies are pointing towards.
Shove the shares in your draw and forget about them for another 5 years.
As the saying goes, "the best investors are dead". Those that can hang on long enough capture growth.
Repeatedly, we see a crop of tiny trades posted, far too small to be trades as we normally think of them. Some kind of financial instrument like CFD's ? Who knows, but they are of no consequence to those holding IMHO. Only a dumbo or a fraud would respond with an expression of impending doom.
I hope you are right ,but i am starting to panic as things are so dull and disappointing ,i just wish i had sold out ,when this was above 1p ,a distant memory now .
The price now is largely irrelevant unless you have to sell or aim to buy more shares. The price will increase when they start making money.
DSM Deal ends if Dec 2022 and new deal starts for Gut Health. Can only assume that Hologram Sciences will be releasing a Gut Health product and that is the 'early commercialisation' they refer to. We will get increased revenue from existing DSM customers from Jan 2023 and new 'pipeline' customers are continuing to come out. Some big ones to come hopefully, as they refer to 'significant multiples' of current income.
BH Deal starts in Jan 2023. News of Blue Hat expected before that (we think). It is expected to be significant in itself. However, we have also read that they have a large number of multinational food and beverage companies that have shown a strong interest in FF or agreed to help with the commercialisation of FF.
After DMS contract ends, we will get more distributors onboard.
Then we are also developing FF as a drug. Will be good to see what progress we have there.
We also have the China Distributor for FF+, also potentially other FF+ distributors. There is this link showing FF+ packaging with Arabic? writing. https://www.behance.net/gallery/126074367/Fruitflow-Packaging-Design?tracking_source=search_projects%7Cfruitflow&fbclid=IwAR2BP1ekq7GBcrEaYx6e231JnX45ddSiFizoO7nDHXTnN_sCFJxOTB8OlUw - Something is afoot.
We have, eventually, the launch of FF+ Nitrates. Surely that should be coming soon. I've got a feeling that will be post DSM agreement, so > 01st Jan 2023. In reality I have no idea.
Plenty going on. As soon as we are turning a profit, there will be an increase in share price. Or big news that guarantees we will turn a profit, like good news out of China.
I think you can call today a down day unless we get a SP turnaround.
Doesn't matter how many times you say it, it was a miniscule trade, as are all the others today.
Strong feeling that you're a MM plant, and not a very good one.
Sorry i don't understand what you mean ,its
been going down for the past 2 months ,and setting a trend
Sorry i don't understand what you mean ,its
been going down for the past 2 months ,and setting a trend
Perhaps they needed the £3.25
I knew this would happen some arse ____ would drag the price down
"Menopause-supporting products the ‘next big opportunity’ according to Lumina report"
"The roles of the microbiome and probiotics in supporting the menopause could be a key growth area as the process, combined with healthy ageing and gut health, gives rise to niche products aimed at women navigating this stage of life.
That’s the view of a new report?? by Lumina that lays bare the emergence of naturally derived treatment options and the market forces combining to create demand."
"Phenology & Frutiflow?
DSM-backed personalised nutrition initiative Hologram Sciences has launched Phenology, its menopause solution that includes a gummy-based daily nutritional supplement regimen for tackling hot flashes and stress.
DSM already make available Fruitflow, an ingredient made from bioactive compounds found in the jelly around tomato seeds.
The ingredient is said to smooth blood platelets, protecting against hyperactivity and unwanted blood clots, which can occur more readily during menopause."
https://www.nutraingredients.com/Article/2022/08/04/Menopause-supporting-products-the-next-big-opportunity-according-to-Lumina-report